Clinical Trials Directory

Trials / Completed

CompletedNCT05261659

Targeted Memory Reactivation During REM Sleep in Patients With Social Anxiety Disorder

Using Sleep and Dreaming to Treat Social Anxiety

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
51 (actual)
Sponsor
University Hospital, Geneva · Academic / Other
Sex
All
Age
16 Years – 40 Years
Healthy volunteers
Not accepted

Summary

With this study, the investigators aim to use sleep and dreaming in order to enhance exposure therapy for social anxiety disorder (SAD), by pairing the positive feedback phase of exposure (public talk) to an auditory stimulus during wake (associated sound) and subsequently applying this stimulus during sleep (targeted memory reactivation, TMR). Exposure therapy sessions will take place in a virtual reality (VR) environment, while physiological measures during the preparation phase of public talk such as heart rate variability (HRV), skin conductance response (SCR) and subjective level of anxiety (SUDS) will be used in order to assess treatment efficiency across the sessions. Patients with SAD according to DSM-5 criteria will be included. The main hypothesis of this study is that participants who are presented with the associated sound during sleep (TMR group) will have reduced intensity of social anxiety compared to participants with no such association (control group), after both a full night's sleep with auditory stimulation during REM sleep in the laboratory, and after 1 week of stimulation during REM sleep at home. In addition, it is expected that fear-related dreams may correlate with anxiety levels during wakefulness after 1 week of stimulation at home.

Conditions

Interventions

TypeNameDescription
BEHAVIORALExposure Therapy and Targeted memory reactivation during REM sleepEmerging evidence shows that REM sleep plays a causal role in extinction learning, emotion regulation and consolidation of emotionally positive memories. By using targeted memory reactivation (TMR), a known method where a sound is associated with a waking experience (i.e., positive feedback in this study) and strengthening it during REM sleep, the investigators aim to accelerate the remission of social anxiety disorder.
BEHAVIORALExposure TherapyThese patients will receive the classic treatment of Exposure Therapy (ET) for social anxiety disorder without any association with a sound.

Timeline

Start date
2020-02-18
Primary completion
2022-02-06
Completion
2022-02-06
First posted
2022-03-02
Last updated
2022-03-14

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05261659. Inclusion in this directory is not an endorsement.